A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders
Authors:
- 6 June 2022
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 75 (2) , 192-195
Abstract
The incidence and prevalence of eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), eosinophilic enteritis (EoN), and eosinophilic colitis (EoC) are increasing (1). These conditions will inevitably become more widely recognized and better understood. There is currently no Food and Drug Administration (FDA)–approved treatment for EoE, but there are standard‐of‐care treatments that are well established and widely used. In contrast, there is a paucity of data regarding standard‐of‐care treatment for non‐EoE eosinophilic gastrointestinal disorders (EGID). We identified 3 patients that all achieved clinical and histopathologic remission on dupilumab, a monoclonal antibody that blocks the downstream signaling of interleukin (IL)‐4 and IL‐13. These patients had extra‐esophageal forms of EGID with two patients failing to achieve remission on standard‐of‐care therapies and one patient experiencing significant side effects on swallowed budesonide therapy. The reduction in mucosal eosinophilia in several GI tract segments in these 3 patients highlights a new potential clinical indication for dupilumab in the treatment of pediatric EGID patients.Keywords
This publication has 9 references indexed in Scilit:
- Eosinophilic Gastritis/GastroenteritisCurrent Gastroenterology Reports, 2021
- Dietary treatment of eosinophilic gastrointestinal disorders in childrenCurrent Opinion in Clinical Nutrition and Metabolic Care, 2020
- Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapiesExpert Review of Clinical Immunology, 2020
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic EsophagitisGastroenterology, 2020
- Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experienceThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Eosinophilic Gastrointestinal Disorders PathologyFrontiers in Medicine, 2018
- Prevalence of Eosinophilic Gastroenteritis and Colitis in a Population-Based Study, From 2012 to 2017Clinical Gastroenterology and Hepatology, 2017
- Open-Capsule Budesonide for Refractory Celiac DiseaseAmerican Journal of Gastroenterology, 2017
- Effect of Six-Food Elimination Diet on Clinical and Histologic Outcomes in Eosinophilic EsophagitisClinical Gastroenterology and Hepatology, 2006